Eli Lilly’s tirzepatide shows promising results for obstructive sleep apnea in latest clinical trials

Eli Lilly and Company (NYSE: LLY) has announced promising results from the SURMOUNT-OSA phase 3 clinical trials of tirzepatide, a novel treatment aimed at moderate-to-severe ... Read More